<DOC>
	<DOCNO>NCT02937857</DOCNO>
	<brief_summary>This multicenter , randomize , open Label , add-on study .</brief_summary>
	<brief_title>An Add-on Study Evaluate Efficacy Safety Xiyanping Injection Pediatric Bronchitis Patients .</brief_title>
	<detailed_description>This add-on study efficacy safety intravenous injection Xiyanping injection subject pediatric bronchitis . The purpose determine efficacy safety conventional treatment combine without Xiyanping injection treatment pediatric bronchitis evaluate clinical value Xiyanping injection shorten course pediatric bronchitis The study enroll 240 Pediatric bronchitis volunteer , randomize 2 group ( 1:1 ratio ) : volunteer first group receive Routine treatment pediatric bronchitis Xiyanping injection ; volunteer second group receive Routine treatment pediatric bronchitis . Xiyanping injection administration intravenous injection 0.2-0.4mL/kg/day daily 5 day concomitantly Routine treatment pediatric bronchitis</detailed_description>
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Acute Disease</mesh_term>
	<mesh_term>Antipyretics</mesh_term>
	<mesh_term>Expectorants</mesh_term>
	<mesh_term>Anti-Asthmatic Agents</mesh_term>
	<criteria>Clinical diagnosis pediatric bronchitis hospital treatment need Males female subject Age 1 3 year old With fever , cough , gasp expectoration symptom Have wheeze and/ midfine rales one 's lung White blood cell count &lt; 12 x 109 / L , categorize priority leukocyte Creactive protein≤8mg/L normal Super C reactive protein Had experience ≤48 h course enrollment Previous Wheezing episodes≤2 Written inform consent Participants severe clinical symptom , meet following： SaO2≤0.92 ; （2）Shock disturbance consciousness ; （3） Significantly speed breathing , rapid pulse accompany severe respiratory distress ; or（4）Repeated occurrence apnea slow irregular respiration ; Acute infectious disease measles , pertussis influenza Participants bronchial asthma , bronchopneumonia respiratory diseases Chronic lung diseases Participants complicate pyopneumothorax , airway obstruction , toxic encephalopathy , cardiac failure respiratory failure Participants complicate severe underlying myocardial , liver , kidney , digestive hematopoietic system disease Severe malnutrition history immune deficiency may seriously affect selflimiting process course Participants epilepsy disturbance central nervous system Participants congenital disease psychosis use antiviral drug within 2 week enrollment use systemic hormone within 2 week enrollment Participants history allergic constitution drug allergy ; Allergenic XiYanPing injection Andrographolide Participants participate clinical research last three month Any condition would make subject , opinion investigator designee , suitable study reason</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>3 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>